Development of enzyme-linked immunosorbent assay for therapeutic drug monitoring of mexiletine

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 6, 2003, Pages 761-765

  Saita, Tetsuya ^a   Fujito, Hiroshi ^a   Mori, Masato ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic drug; ELISA; Mexiletine

Indexed keywords

2 HYDROXYMETHYLMEXILETINE; 4 HYDROXYMEXILETINE; BETA GALACTOSIDASE; DRUG METABOLITE; GLUTARALDEHYDE; MEXILETINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; REPRODUCIBILITY;

EID: 10644270806     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.761     Document Type: Article

References (20)

1. Gillis A. M., Kates R. E., Clin. Pharmacokinet., 9, 375-403 (1984).
2. Prescot L. F., Clements J. A., Pottage A., Postgrad Med J, 53, 50-55 (1977).
3. Woosley R. L., Wang T., Stone W., Sidoway L., Thompson K., Duff H. J., Cerkus I., Roden D., Am. Heart J., 107, 1058-1070 (1984).
4. Haselbarth V., Doevendans J E., Wolf M., Clin Pharmacol. Ther., 29, 729-736 (1981).
5. Johnston A., Burgess C. D., Warrington S. J., Wadsworth J., Hamer N. A J., Br J. Clin. Pharmacol., 8, 349-352 (1982).
6. Campbell N. P. S., Kelly J. G., Adgey A. A. J., Shanks R. G., Br. J. Clin. Pharmacol., 6, 103-108 (1978).
7. Holt D. W., Flanagan J., Hayler A. M., Loizou M., J. Chromatogr., 169, 295-301 (1979).
8. Breithaupt H., Wilfling M., J. Chromatogr., 230, 97-105 (1982).
9. Dusci L. J., Hackett L. P., J. Anal. Toxicol., 9, 67-70 (1985).
10. Minnigh M. B., Alvin J. D., Zemaitis M. A., J Chromatogr. B, 662, 118-122 (1994).
11. Klotz I. M., Heiney R. E., Arch Biochem. Biophys., 96, 605-612 (1962).
12. Imagawa M., Hashida S., Ishikawa E., Sumiyoshi A., J Appl. Biochem., 4, 400-410 (1982).
13. Onoue K., Yagi Y., Pressman D., J. Immunol., 92, 173-184 (1964).
14. Kelly R., Chritmore D., Smith R., Doshier L., Jacobs S. L., Ther. Drug Monitor., 3, 279-286 (1981).
15. Scott K. N., Cough M. W., Wilder B. J., Williams C. M., Drug Metab. Dispos., 1, 506-515 (1973).
16. Beckett A. H., Chidomere E. C., Postgrad. Med. J, 53, 60-66 (1977).
17. Grech-Belanger O., Gilbert M., Turgeon J., LeBlanc P. P., Clin. Pharmacol. Ther., 37, 638-643 (1985).
18. Freitag D. G., Foster R. T., Coutts R. T., Pickard M. A., Pasutto F. M., Drug Metab Dispos., 25, 685-692 (1997).
19. Bruno R., Santoni Y., Iliadis A., Djiane P., Serradimigm A., Cano J. P., Biopharm. Drug Dispos., 13, 481-493 (1992).
20. Labbe L., O'Hara G., Lefebvre M., Lessard E., Gilbert M., Adedoyin A., Champagne J., Hamelin B., Turgeon J., Clin. Pharmacol Ther., 68, 44-57 (2000).